HCV prodrug therapy (Twinstrand)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHCV prodrug therapy (Twinstrand)
Drug Alias Namehepatitis C virus prodrug therapy (Twinstrand)TST-500 seriesHCV protease-activating prodrugs (Twinstrand)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTwinstrand Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTwinstrand Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A